Skip to the page

Data / Form D filings / ORAGENICS INC

ORAGENICS INC: Form D filings

ORAGENICS INC, a biotechnology company in Tampa, FL, filed 13 Form D notices with the SEC between 2010 and 2023. The latest, on August 8, 2023, reports $850,000 sold of a $850,000 offering to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
4902 EISENHOWER BOULEVARD, SUITE 125, Tampa, FL, 33634
Phone
(813) 286-7900
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Florida
Revenue range
No Revenues
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1174940

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 8, 2023New notice$850,000$850,0002Aug 4, 2023sec.gov
May 6, 2020New noticeIndefinite$4,600,0001May 1, 2020sec.gov
Apr 12, 2018New notice$1,800,000$1,800,0002Apr 10, 2018sec.gov
Nov 14, 2017New notice$6,676,209$6,676,2095Nov 8, 2017sec.gov
May 19, 2017New notice$3,000,000$1,302,292$1,697,7083May 10, 2017sec.gov
Jul 13, 2016New notice$4,666,666$4,666,6663Jun 30, 2016sec.gov
Oct 15, 2013New notice$9,900,000$9,900,0001Sep 30, 2013sec.gov
Aug 10, 2012New notice$2,538,185$2,538,1851Jul 31, 2012sec.gov
Aug 10, 2012New notice$13,000,000$13,000,00053Jul 31, 2012sec.gov
Jun 15, 2012New notice$5,798,001$5,798,0011Jun 5, 2012sec.gov
Apr 5, 2012New notice$11,237,011$11,237,0111Mar 23, 2012sec.gov
Aug 11, 2010New notice$2,000,000$2,000,0001Jul 30, 2010sec.gov
Jan 13, 2010New notice$3,000,000$3,000,0009Dec 30, 2009sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Alan DuntonDirector
Frederick TellingDirector
Kimberly MurphyExecutive Officer, Director
Janet HuffmanExecutive Officer
Charles PopeDirector
Robert KoskiDirector

Other biotechnology companies in Florida that filed recently

Every Form D from the week of Aug 7, 2023 · All recent filings in Florida · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what ORAGENICS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.